Szerman Nestor, Peris Lola
a Servicio de Psiquiatría , Hospital Universitario Gregorio Marañon , Madrid , Spain.
b Research Unit and Dual Disorders Program, Centre Neuchâtelois de Psychiatrie (CNP) , Neuchâtel , Switzerland.
J Dual Diagn. 2018 Oct-Dec;14(4):237-246. doi: 10.1080/15504263.2018.1512727. Epub 2019 Jan 14.
Addiction co-occurs with distinct pathological personality traits, other psychiatric disorders or symptoms and cognitive impairment, which are known as dual disorders or co-occurring disorders. This symptomatic high concurrency suggests that both conditions are in some ways causally linked. Research is ongoing to identify distinctive neurobehavioral mechanisms and endophenotypes that predispose individuals to compulsive drug use and other mental disorders. Research is also providing new revelations about the diverse effects of substances on individuals, including differences according to sex. Today we know that the same substance may give rise to different behavioral, affective, cognitive, and sensory effects across different individuals.
This state-of the art review tends to address the concept of precision psychiatry and dual disorders. The PubMed database was searched for the last 15 years to identify those articles that reported neurobiological perspectives on dual disorders, addiction and other mental disorders, precision medicine, and precision psychiatry.
There has been considerable progress made in recent years in relation to the study of addiction and dual disorders. The concept of dual disorders attempts to capture not only the persistence of substance use and substance seeking but also the evident vulnerability of specific subpopulations to switch from controlled to compulsive drug use. Precision medicine is focused on identifying this individual vulnerability to illness as much as the individual response to treatment. Psychiatry is fully committed to this goal. Regarding addiction, essential precision medicine advances will be possible if concerted efforts are made in the discovery of biological variations and environmental factors that contribute to individual vulnerability to addictive disorders and dual disorders, together with the identification of moderators of treatment response.
Here we survey the discoveries, future research directions, and translational relevance of the concept of precision psychiatry for dual disorders. The review may offer new perspectives on this issue and highlight a new way to see and to think about dual disorders.
成瘾常与独特的病理性人格特质、其他精神障碍或症状以及认知障碍同时出现,这些被称为双重障碍或共病障碍。这种症状的高度并发表明这两种情况在某些方面存在因果联系。目前正在进行研究,以确定导致个体易患强迫性药物使用和其他精神障碍的独特神经行为机制和内表型。研究还揭示了物质对个体的多种影响,包括性别差异。如今我们知道,同一种物质在不同个体身上可能会产生不同的行为、情感、认知和感官效应。
本前沿综述旨在探讨精准精神病学和双重障碍的概念。检索了过去15年的PubMed数据库,以确定那些报道了关于双重障碍、成瘾和其他精神障碍、精准医学和精准精神病学的神经生物学观点的文章。
近年来,在成瘾和双重障碍的研究方面取得了相当大的进展。双重障碍概念不仅试图捕捉物质使用和寻求行为的持续性,还试图捕捉特定亚群体从可控药物使用转变为强迫性药物使用的明显易感性。精准医学既关注识别个体对疾病的易感性,也关注个体对治疗的反应。精神病学完全致力于这一目标。关于成瘾,如果能共同努力发现导致个体易患成瘾性障碍和双重障碍的生物学变异和环境因素,并确定治疗反应的调节因素,那么精准医学的重要进展将是可能的。
在此,我们综述了精准精神病学概念对于双重障碍的发现、未来研究方向及转化相关性。本综述可能会为这个问题提供新的视角,并突出一种看待和思考双重障碍的新方式。